| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Magdalena Świądro-Piętoń, Dominika Dudek, Renata Wietecha-Posłuszn. Direct Immersion-Solid Phase Microextraction for Therapeutic Drug Monitoring of Patients with Mood Disorders. Molecules (Basel, Switzerland). vol 29. issue 3. 2024-02-10. PMID:38338419. |
it has been adapted to identify the most commonly used drugs in mood disorders, including amitriptyline, citalopram, fluoxetine, paroxetine, sertraline, trazodone, duloxetine, venlafaxine, lamotrigine, quetiapine, olanzapine, and mirtazapine. |
2024-02-10 |
2024-02-12 |
Not clear |
| Gudrun Hefner, Jan Wolff, Sermin Toto, Pamela Reißner, Ansgar Klimk. Off-label use of antidepressants, antipsychotics, and mood-stabilizers in psychiatry. Journal of neural transmission (Vienna, Austria : 1996). 2022-09-07. PMID:36070009. |
the most often off-label prescribed drugs were quetiapine and mirtazapine for organic mental disorders (f0/g3), valproate and quetiapine in patients with disorders due to psychoactive substance use (f1), valproate in patients with psychotic disorders (f2), and risperidone and olanzapine in patients with affective disorders (f3). |
2022-09-07 |
2023-08-14 |
Not clear |
| Przemysław Sołek, Jennifer Mytych, Anna Tabęcka-Łonczyńska, Marek Koziorowsk. Molecular Consequences of Depression Treatment: A Potential In Vitro Mechanism for Antidepressants-Induced Reprotoxic Side Effects. International journal of molecular sciences. vol 22. issue 21. 2021-11-18. PMID:34769286. |
to directly test reprotoxicity, the spermatogenic cells (gc-1 spg and gc-2 spd cells) were incubated for 48 and 96 h with amitriptyline (hydrochloride) (ami), escitalopram (esc), fluoxetine (hydrochloride) (flu), imipramine (hydrochloride) (imi), mirtazapine (mir), olanzapine (olz), reboxetine (mesylate) (reb), and venlafaxine (hydrochloride) (ven), and several cellular and biochemical features were assessed. |
2021-11-18 |
2023-08-13 |
mouse |
| Marilia Bernardes, Saberio Lo Presti, Kenneth Ratza. A Case of Cephalic Tetanus in an Elderly Patient with Trismus. Case reports in infectious diseases. vol 2018. 2020-10-01. PMID:30046499. |
psychiatry was consulted, and the patient was prescribed olanzapine and mirtazapine for suspected depression with somatization symptoms. |
2020-10-01 |
2023-08-13 |
Not clear |
| David J Cangemi, Braden Ku. Practical Perspectives in the Treatment of Nausea and Vomiting. Journal of clinical gastroenterology. vol 53. issue 3. 2020-08-11. PMID:30614944. |
recently, neuromodulator agents, such as tricyclic antidepressants, gabapentin, olanzapine, mirtazapine, and benzodiazepines, and cannabinoids have been shown to be efficacious in the treatment of nausea and vomiting, and may be useful in the treatment of chronic symptoms. |
2020-08-11 |
2023-08-13 |
Not clear |
| Chi-Shun Wu, Show-Hwa Tong, Cheung-Ter Ong, Sheng-Feng Sun. Serotonin Syndrome Induced by Combined Use of Mirtazapine and Olanzapine Complicated with Rhabdomyolysis, Acute Renal Failure, and Acute Pulmonary Edema-A Case Report. Acta neurologica Taiwanica. vol 24. issue 4. 2016-12-23. PMID:27333965. |
serotonin syndrome induced by combined use of mirtazapine and olanzapine complicated with rhabdomyolysis, acute renal failure, and acute pulmonary edema-a case report. |
2016-12-23 |
2023-08-13 |
Not clear |
| Catalina Ayala Corredor, Carolina Solís Castill. [Other Possible Clinical Applications of Drugs with 5HT2A effect in Liaison Psychiatry: Cases Report]. Revista colombiana de psiquiatria. vol 41. issue 1. 2015-11-24. PMID:26573480. |
some particular cases motivated the description, report and review about other possible applications of 5ht2a and 5ht3 antagonist, particularly mirtazapine and olanzapine, in hyperalgesia syndrome, tinnitus and progressive multifocal leukoencephalopathy by jc virus. |
2015-11-24 |
2023-08-13 |
Not clear |
| S Buggenhout, J Vandenberghe, P Sienaer. [Electroconvulsion therapy for neuroleptic malignant syndrome]. Tijdschrift voor psychiatrie. vol 56. issue 9. 2014-12-02. PMID:25222100. |
a 64-year-old man, diagnosed with recurrent depression, developed a neuroleptic malignant syndrome (nms) during treatment with olanzapine and mirtazapine. |
2014-12-02 |
2023-08-13 |
Not clear |
| Grazia Caforio, Annabella Di Giorgio, Antonio Rampino, Miriam Rizzo, Raffaella Romano, Paolo Taurisano, Leonardo Fazio, Giuseppe De Simeis, Gianluca Ursini, Giuseppe Blasi, Marcello Nardini, Michele Mancini, Alessandro Bertolin. Mirtazapine add-on improves olanzapine effect on negative symptoms of schizophrenia. Journal of clinical psychopharmacology. vol 33. issue 6. 2014-09-15. PMID:24113675. |
mirtazapine add-on improves olanzapine effect on negative symptoms of schizophrenia. |
2014-09-15 |
2023-08-12 |
Not clear |
| Michele Fornaro, Matteo Martin. Adding 5-hydroxytryptamine receptor type 3 antagonists may reduce drug-induced nausea in poor insight obsessive-compulsive patients taking off-label doses of selective serotonin reuptake inhibitors: a 52-week follow-up case report. Annals of general psychiatry. vol 9. issue 1. 2011-07-14. PMID:21143969. |
both mirtazapine and olanzapine also act as 5-hydroxytryptamine receptor type 3 (5-ht3) blockers, making them preferred choices especially in cases of drug-induced nausea. |
2011-07-14 |
2023-08-12 |
Not clear |
| Paola Devoto, Giovanna Flor. On the origin of cortical dopamine: is it a co-transmitter in noradrenergic neurons? Current neuropharmacology. vol 4. issue 2. 2010-06-09. PMID:18615131. |
moreover, microdialysis studies in rats have shown how pharmacological treatments that induce modifications of extracellular na in the medial pfc (mpfc), also produce parallel changes in extracellular da.to explain the coupling of na and da changes, this article reviews the evidence supporting the hypothesis that extracellular da in the cerebral cortex originates not only from dopaminergic terminals but also from noradrenergic ones, where it acts both as precursor for na and as a co-transmitter.accordingly, extracellular da concentration in the occipital, parietal and cerebellar cortex was found to be much higher than expected in view of the scarce dopaminergic innervation in these areas.systemic administration or intra-cortical perfusion of alpha(2)-adrenoceptor agonists and antagonists, consistent with their action on noradrenergic neuronal activity, produced concomitant changes not only in extracellular na but also in da in the mpfc, occipital and parietal cortex.chemical modulation of the locus coeruleus by locally applied carbachol, kainate, nmda or clonidine modified both na and da in the mpfc.electrical stimulation of the locus coeruleus led to an increased efflux of both na and da in mpfc, parietal and occipital cortex, while in the striatum, na efflux alone was enhanced.atypical antipsychotics, such as clozapine and olanzapine, or antidepressants, including mirtazapine and mianserine, have been found to increase both na and da throughout the cerebral cortex, likely through blockade of alpha(2)-adrenoceptors. |
2010-06-09 |
2023-08-12 |
rat |
| S Spyridi, S Sokolaki, J Nimatoudis, A Iacovides, G Kaprini. Status epilepticus in a patient treated with olanzapine and mirtazapine. International journal of clinical pharmacology and therapeutics. vol 47. issue 2. 2009-03-24. PMID:19203568. |
our objective was to report a case of status epilepticus in a patient receiving olanzapine and mirtazapine, with no previous history of seizure and no confirmed underlying cause for seizure. |
2009-03-24 |
2023-08-12 |
Not clear |
| S Spyridi, S Sokolaki, J Nimatoudis, A Iacovides, G Kaprini. Status epilepticus in a patient treated with olanzapine and mirtazapine. International journal of clinical pharmacology and therapeutics. vol 47. issue 2. 2009-03-24. PMID:19203568. |
status epilepticus in a patient treated with olanzapine and mirtazapine. |
2009-03-24 |
2023-08-12 |
Not clear |
| E Wezenberg, B G C Sabbe, W Hulstijn, G S F Ruigt, R J Verke. The role of sedation tests in identifying sedative drug effects in healthy volunteers and their power to dissociate sedative-related impairments from memory dysfunctions. Journal of psychopharmacology (Oxford, England). vol 21. issue 6. 2007-10-18. PMID:17092974. |
lorazepam and olanzapine impeded memory performance, whereas mirtazapine did not. |
2007-10-18 |
2023-08-12 |
human |
| D Cardon. [Pharmacological therapy of cancer anorexia-cachexia]. Nutricion hospitalaria. vol 21 Suppl 3. 2006-10-26. PMID:16768027. |
from the knowledge of the different mechanisms producing the anorexia-cachexia syndrome, hypercaloric diets for artificial nutrition have been studied with varying success, and different drugs with a positive effect on appetite gain such as progestogens, steroids, and with lesser clinical evidence cannabinoids, cyproheptadine, mirtazapine (antidepressant), and olanzapine (antipsychotic). |
2006-10-26 |
2023-08-12 |
Not clear |
| Tzong-Shi Wang, Yuan-Hwa Chou, I-Shin Shia. Combined treatment of olanzapine and mirtazapine in anorexia nervosa associated with major depression. Progress in neuro-psychopharmacology & biological psychiatry. vol 30. issue 2. 2006-06-08. PMID:16314020. |
our case suggests that the combined treatment of olanzapine and mirtazapine can be used in the treatment of an associated with major depression. |
2006-06-08 |
2023-08-12 |
Not clear |
| Tzong-Shi Wang, Yuan-Hwa Chou, I-Shin Shia. Combined treatment of olanzapine and mirtazapine in anorexia nervosa associated with major depression. Progress in neuro-psychopharmacology & biological psychiatry. vol 30. issue 2. 2006-06-08. PMID:16314020. |
combined treatment of olanzapine and mirtazapine in anorexia nervosa associated with major depression. |
2006-06-08 |
2023-08-12 |
Not clear |
| Sanjeev Ranjan, Prabha S Chandra, Santosh K Chaturvedi, Santosh C Prabhu, Arun Gupt. Atypical antipsychotic-induced akathisia with depression: therapeutic role of mirtazapine. The Annals of pharmacotherapy. vol 40. issue 4. 2006-06-01. PMID:16569791. |
to investigate the efficacy of mirtazapine in treating akathisia caused by risperidone and olanzapine, as well as its use in alleviating comorbid depressive disorder. |
2006-06-01 |
2023-08-12 |
Not clear |
| Todd W Matto. Treatment of unintentional weight loss in patients with cancer. Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition. vol 20. issue 4. 2006-01-26. PMID:16207680. |
a variety of agents have been studied for their positive effects on appetite, including progestational agents, glucocorticoids, cannabinoids, cyproheptadine, olanzapine, and mirtazapine. |
2006-01-26 |
2023-08-12 |
Not clear |
| Gabriele Mas. Pharmacotherapy of pervasive developmental disorders in children and adolescents. CNS drugs. vol 18. issue 14. 2004-12-29. PMID:15584771. |
pharmacological, efficacy and safety data on drugs acting on serotonin (serotonergic agents such as clomipramine, fluoxetine, paroxetine, sertraline, citalopram and fluvoxamine), on both serotonin and norepinephrine (venlafaxine and mirtazapine), dopamine (dopamine-blocking antipsychotics such as haloperidol and pimozide), and on both serotonin and dopamine (atypical antipsychotics such as clozapine, risperidone, olanzapine, quetiapine and ziprasidone) are presented. |
2004-12-29 |
2023-08-12 |
Not clear |